Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) (ROSORC)
This study has been completed.
Sponsor:
Italian Trial in Medical Oncology
Information provided by:
Italian Trial in Medical Oncology
ClinicalTrials.gov Identifier:
NCT00609401
First received: January 11, 2008
Last updated: February 25, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2008 |
| Primary Completion Date: | May 2007 (Final data collection date for primary outcome measure) |